Compugen (CGEN), which last week signed a big collaboration deal with Pfizer (PFE), is up 34%...

|About: Compugen Ltd. (CGEN)|By:, SA News Editor

Compugen (CGEN), which last week signed a big collaboration deal with Pfizer (PFE), is up 34% premarket after announcing the discovery and experimental validation of a new drug target for multiple epithelial tumors, whose carcinomas account for approximately 85% of all cancers.